MDA Clinical and Scientific Conference 2022
Evaluation Of Complement C3 Inhibition In Ameliorating ALS Disease Phenotypes Using A Human-On-A-Chip Neuromuscular Junction System
Landing
Back to Conference Resources
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.